Stopping and Restarting Certain GLP-1s to Lose Weight May Make the Drug Less Effective

What you and the other user described happens fairly often even though their time off was longer. Some people believe long breaks will reset the receptors but I have not seen supporting science. What shows up more are stories like yours where earlier use seems to blunt later response to the same or another medication. The positive part is you returned to your earlier weight and are losing again which is encouraging for others.

I only skimmed the paper but the design is intriguing. It would have been useful to see a schedule closer to four months continuous versus two months on one month off and one month on. Maybe rat time scales differently from human months. The work feels preliminary probably aimed at keeping funding. Still there may be real physiological shifts beyond just hunger returning such as changes in fat versus lean mass or set point. My guess is the weight regained after stopping is part of what causes the problem possibly involving insulin or ghrelin.

I have no faith in the reset idea. My results show clearly that it does not happen. It is also very frustrating to lose months of progress on a test that did not pay off. I did not expect it to take three or four months plus a higher dose. If anyone is thinking about trying it I would advise against it. Stay consistent instead.

I agree completely. My own plan is not to cycle off. I may lower the dose or space injections further and adjust as needed but I intend to keep going. This approach works better.

The data does not back the idea that people reach a stable metabolically healthy state even after time. For those with an underlying issue that caused obesity the medication treats it but does not cure it. The SURMONT graph shows a nearly flat line for almost two years on treatment. Once people stopped at week 176 the weight rose. There is no sign the flat line would have changed while on the drug but also no sign the rebound would not occur if stopped later.

The study focuses on cycling rather than the choice to stay on or stop for good. Cycling can occur for many reasons some planned and some not. Surgeons often require time off before procedures. Travel can make carrying medication difficult. Switching between different GLP-1s also counts as cycling and prior exposure can mean the new one needs higher doses to work well.

That would be my biggest worry too. Guidelines have shortened the required time off for procedures but I would still feel anxious about even two weeks without it.

That is why I plan to stay on as long as possible though at a lower dose than now. I have time to work out the details. The article and discussion are useful.

You might be one of the people who can eventually manage without the medication. Much depends on how severe the original metabolic problem was. Some started from a worse place than others. There is no single answer. I think some will maintain without ongoing use but they are probably not the group these drugs were first meant for.

You are probably right. My situation was not as severe as many here. Still I am glad the medications exist because even a modest reduction in food noise has improved daily life more than I expected. I am cautiously hopeful about how it will go.

What was your starting height and weight?

I suspected that was the case. No judgment either way on who should use them. The original target population does not mean others cannot benefit. These drugs were not first aimed at alcohol use disorder yet that group seems to gain a lot. Maybe one day they will be viewed as reasonable for overweight people too. Good for you for finding something that helps. We just need to avoid blanket assumptions in either direction.

Before reta I weighed 230 pounds at six foot two. My highest was 280 about five years ago. I am down to 209 after five weeks.

That is a fair point. Context matters and what works for one person is not a guide for everyone. Thanks for adding that perspective.

Thanks for sharing that study. It matches what I went through. The steep rebound after week 176 is especially striking and is one reason I probably will not stop completely.

These medications are gaining attention in longevity circles for heart benefits and lower mortality risk. More people at normal weight are now using low doses for those reasons. We will see what the data shows in ten years.

I feel the same about medication in general. I started tirz after already losing ninety pounds and building better eating patterns. I did not expect to reach such a low body-fat level. Maintaining the lower weight has not been harder than maintaining higher weights because the food noise was always strong. Tirz has made daily life better and appears to offer health benefits beyond the scale. It also seems to have normalized my metabolism relative to my activity level. I do not plan to stop unless long-term safety data changes significantly.

I am microdosing a statin now because of benefits beyond cholesterol. My LDL was only slightly high originally and is now fine so I cut the pills and skip days to keep the dose low. The reason is that very low cholesterol began affecting testosterone production. The body apparently needs some fat in the blood for that.

I have also seen online talk about giving receptors a break to reset but nothing from researchers supports it. The idea probably comes from trying to explain plateaus or weaker appetite control. Those changes are more likely normal body adaptations. Some drugs do cause true receptor tolerance such as opioids but that pattern has not appeared with GLP-1s in practice. If receptors were burning out we would see worsening blood sugar hunger rebound and weight gain along with no response to higher doses. The SURMONT data would not look flat if that were happening.

That matches my experience after losing coverage and going three months without sema. Getting the weight loss going again has been uneven and frustrating.

The study is interesting. The 20 percent difference seems large enough to suggest cycling might be worse than no treatment at all. Human trials are needed but unlikely to be funded by the major companies. Those companies appear to assume continued use without pauses. Their pricing also encourages staying on the medication.

That is my view as well. The improvement in my cholesterol numbers has been a big plus. My doctor had said I would need to watch it but recent tests have been good.

We are giving far higher amounts of exogenous GLP-1 than the body normally makes. That would be dangerous in a TRT context. Quick checks suggest TRT uses two to three times natural levels while tirzepatide at 15 mg is roughly one hundred to one thousand times natural GLP-1. Taking six to sixty grams of testosterone cypionate weekly would be extreme.

I usually just say I am supplementing with T to keep it short. The replacement therapy label does not fit perfectly here anyway. With TRT you are restoring something the body cannot make enough of. Most people with obesity are not GLP-1 deficient and the doses used are well above normal physiology. Native GLP-1 also has a half-life of minutes while these drugs create a steady week-long signal the body never produces on its own. That is a new approach rather than simple replacement.

The body is complex and many mechanisms behind obesity remain unclear but there is clearly some signaling problem in most obese individuals. The amylin papers are especially interesting right now. One from 2012 only speculated that amylin might help with weight loss. Fourteen years later another compound acting on that pathway is showing results comparable to GLP-1 drugs and even approaching surgical levels of loss. That suggests obesity involves multiple pathways that can be targeted.

Studies suggest fat cells retain a memory of their largest size and live about eight years. It will be worth watching what happens to people who maintain goal weight for many years before stopping. If enough of the original fat cells die off perhaps a new set point becomes possible. I would like to stop eventually but plan to maintain for several more years first.

Any chance of sharing some positive notes in this thread?

The good news is that staying on the medication without breaks keeps you in the group that maintains the lower weight like the consistent rats in the study.

No one knows what will be available years from now so it is not worth fixating on lifelong use. Think of it as the foreseeable future especially if you are younger. These drugs correct signaling problems and genetics likely play a role so future gene therapies could change things. New options like monthly injectables or pills may also make maintenance easier. The pipeline for obesity treatments looks promising despite frustrations with the companies involved.